Home

MDV VII Leaders' Fund, L.P.

CIK 1605840 · last filed 2016-09-09

MDV VII Leaders' Fund, L.P. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 1 company since 2015. The most recent filing shows the insider bought $8.6M of ADMS on Sep 9, 2016. Across all open-market trades the lifetime net is −$6.7M, making them a net seller over the disclosed history. The firm reports its address in Menlo Park, CA. 12 SEC filings were submitted jointly with JONATHAN D FEIBER.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

4

Lifetime Open-Market Net

-$6.66M

Filer Profile

Reported Address
3000 SAND HILL ROAD
BUILDING 3, SUITE 290
MENLO PARK, CA 94025
Phone
(650) 854-7236
State of Incorporation
DE
Related Filers
JONATHAN D FEIBER — 12 joint filings, latest 2016-09-16
MDV ENF VII (B), L.P. — 12 joint filings, latest 2016-09-16
MDV IX LP — 12 joint filings, latest 2016-09-16
MDV VII LP — 12 joint filings, latest 2016-09-16
Ninth MDV Partners, L.L.C. — 12 joint filings, latest 2016-09-16
NANCY J SCHOENDORF — 12 joint filings, latest 2016-09-16
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Adamas Pharmaceuticals Inc (ADMS) Delisted 10%+ Owner 6,043 $8.22 $49.7K -$6.66M 4 2016-09-09

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-09-09 Adamas Pharmaceuticals Inc (ADMS) Delisted Buy (P) +547,614 $8.59M EDGAR
2015-07-09 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −259,533 -$7.15M EDGAR
2015-04-14 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −333,702 -$6.19M EDGAR
2015-03-19 Adamas Pharmaceuticals Inc (ADMS) Delisted Sell (S) −105,507 -$1.90M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.